BEST EVIDENCE TOPIC REPORT
Use of Heliox in the management of acute exacerbation of COPD
The Queen Elizabeth Hospital, Kings Lynn
Report by Dhananjay Kumar, SpR in Emergency Medicine
Checked by Rajesh Kumar Saksena, SpR in Medicine
The Queen Elizabeth Hospital, Kings Lynn
| The first 150 words of the full text of this article appear below. |
In [patients with acute COPD] does [the administration of heliox] improve [survival, Peak flow, reduce time in hospital or reduce the need for mechanical ventilation]?
A 45-year-old male smoker attends the emergency department with exacerbation of chronic obstructive pulmonary disease. Repeated doses of nebulised Salbutamol and Ipratropium Bromide has been administered and Aminophyllin infusion has been commenced. You feel that the patient will require intubation and ventilation. You have got access to Heliox and you feel that it might improve the condition of the patient and might avoid intubation. Is there any evidence to support use of Heliox in such situation?
Medline (1951 to date) Embase (1974 to date)
Dialog Datastar web (Athens) search terms [HELIUM#.W..DE., OXYGEN#.W..DE. and PULMONARY-DISEASE-CHRONIC-OBSTRUCTIVE#.DE.]-
Cochrane Library: Heliox
Reference review: A search of references from articles found by electronic searching was done.
BOC Medical Group: (manufacturer firm for Heliox) was contacted. No new articles found.
Altogether
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
